🇺🇸 FDA
Pipeline program

Indiplon

A5761022

Phase 3 small_molecule terminated

Quick answer

Indiplon for Insomnia is a Phase 3 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
NEUROCRINE BIOSCIENCES INC
Indication
Insomnia
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials